HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Özlem Türeci Selected Research

Ligands

5/2020PLAC1 is essential for FGF7/FGFRIIIb-induced Akt-mediated cancer cell proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Özlem Türeci Research Topics

Disease

55Neoplasms (Cancer)
05/2024 - 01/2011
22COVID-19
03/2024 - 10/2020
8Infections
01/2023 - 01/2019
5Adenocarcinoma
08/2023 - 09/2019
4Breakthrough Infections
01/2023 - 01/2022
4Melanoma (Melanoma, Malignant)
01/2020 - 10/2011
3Pancreatic Neoplasms (Pancreatic Cancer)
05/2024 - 02/2014
3Breast Neoplasms (Breast Cancer)
05/2020 - 09/2015
3Communicable Diseases (Infectious Diseases)
01/2017 - 10/2014
2Human Influenza (Influenza)
09/2023 - 01/2020
2Stomach Neoplasms (Stomach Cancer)
01/2023 - 09/2019
2Headache (Headaches)
01/2021 - 12/2020
2Pain (Aches)
01/2021 - 12/2020
2Fatigue
01/2021 - 12/2020
2Neoplasm Metastasis (Metastasis)
01/2017 - 01/2011
2Testicular Neoplasms (Testicular Cancer)
11/2015 - 03/2014
1Myocarditis (Carditis)
03/2024
1Pericarditis
03/2024
1Fever (Fevers)
01/2023
1Hypoxia (Hypoxemia)
08/2022
1Disease Progression
05/2021
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021
1Multiple Sclerosis
01/2021
1Severe Acute Respiratory Syndrome
10/2020
1Choriocarcinoma
05/2020
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Lymphatic Metastasis
09/2019
1Carcinoma (Carcinomatosis)
01/2019
1Inflammation (Inflammations)
01/2019
1Vaccinia
12/2017
1Lung Neoplasms (Lung Cancer)
11/2015
1Triple Negative Breast Neoplasms
09/2015

Drug/Important Bio-Agent (IBA)

33VaccinesIBA
09/2023 - 01/2011
24AntigensIBA
11/2023 - 01/2011
17BNT162 VaccineIBA
03/2024 - 10/2020
17mRNA VaccinesIBA
03/2024 - 10/2011
16Messenger RNA (mRNA)IBA
03/2024 - 06/2011
15RNA (Ribonucleic Acid)IBA
06/2023 - 10/2011
9EpitopesIBA
01/2022 - 01/2011
8Proteins (Proteins, Gene)FDA Link
05/2024 - 03/2016
6zolbetuximabIBA
08/2023 - 02/2014
5Peptides (Polypeptides)IBA
01/2021 - 01/2016
4ClaudinsIBA
05/2024 - 02/2014
4claudin 6IBA
11/2023 - 03/2016
4Cancer VaccinesIBA
01/2020 - 06/2011
3Monoclonal AntibodiesIBA
03/2024 - 01/2018
3Chimeric Antigen ReceptorsIBA
11/2023 - 01/2020
3Immunoglobulin G (IgG)IBA
09/2023 - 10/2020
3N-(2-cyanoethylene)urea (BA 1)IBA
12/2022 - 01/2022
3N-methyl-valyl-amiclenomycin (BA 2)IBA
12/2022 - 01/2022
3AntibodiesIBA
01/2022 - 01/2011
3Immune Checkpoint InhibitorsIBA
01/2022 - 04/2016
3cyclopropapyrroloindoleIBA
01/2022 - 01/2020
2Interleukin-2 (IL2)IBA
03/2024 - 08/2023
2Tight Junction ProteinsIBA
01/2023 - 01/2020
2Neutralizing AntibodiesIBA
12/2022 - 01/2020
2CytokinesIBA
01/2022 - 10/2020
2Biomarkers (Surrogate Marker)IBA
09/2019 - 12/2014
2Bispecific AntibodiesIBA
10/2017 - 07/2017
2flt3 ligand protein (flt3 ligand)IBA
01/2016 - 10/2011
1Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
05/2024
1LipidsIBA
05/2024
1TetraspaninsIBA
05/2024
1Histocompatibility Antigens Class IIBA
03/2024
1Zoledronic Acid (Zometa)FDA Link
08/2023
1Recombinant ProteinsIBA
01/2023
1AcidsIBA
12/2022
1Immune Sera (Antisera)IBA
12/2022
1Glycoproteins (Glycoprotein)IBA
12/2022
1Therapeutic UsesIBA
08/2022
1COVID-19 VaccinesIBA
01/2022
1EnzymesIBA
01/2022
1InterferonsIBA
01/2021
1Lipid NanoparticlesIBA
10/2020
1NucleosidesIBA
10/2020
1LigandsIBA
05/2020
1Phosphatidylinositols (Phosphatidylinositol)IBA
05/2020
1Cystine-Knot MiniproteinsIBA
01/2020
1Coloring Agents (Dyes)IBA
01/2020
1Hemagglutinins (Hemagglutinin)IBA
01/2020
1Fibronectins (Fibronectin)IBA
01/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2020
1NucleotidesIBA
01/2019
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019
1Oncogene Proteins (Oncogene Protein)IBA
01/2019
1Toll-Like Receptor 7IBA
01/2019
1Tumor Biomarkers (Tumor Markers)IBA
03/2016
1Estrogens (Estrogen)FDA Link
01/2016
1Antiviral Agents (Antivirals)IBA
01/2016
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2015
1Tumor Viral Antigens (Large T Antigen)IBA
11/2015
1TensinsIBA
11/2015
1AutoantibodiesIBA
11/2015

Therapy/Procedure

23Immunotherapy
05/2024 - 01/2011
12Therapeutics
08/2022 - 06/2011
3Radiotherapy
03/2024 - 01/2020
2Drug Therapy (Chemotherapy)
01/2023 - 09/2019
1Transcutaneous Electric Nerve Stimulation (TENS)
12/2020
1Premedication
01/2020
1Combination Drug Therapy (Combination Chemotherapy)
09/2019